Filtros de búsqueda

Lista de obras de Pavel Klener

A novel fibrinogen variant--Praha I: hypofibrinogenemia associated with gamma Gly351Ser substitution.

artículo científico publicado en 2007

Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma.

artículo científico publicado en 2017

Biallelic IgH rearrangements in patients with indolent lymphoproliferative disorders: molecular and practical implications.

artículo científico publicado en 2004

Distinguishing of primary mediastinal B-cell lymphoma and diffuse large B-cell lymphoma using real-time quantitative polymerase chain reaction

artículo científico publicado en 2010

Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia

scientific article published on 03 April 2007

Insights into gene expression changes impacting B-cell transformation: cross-species microarray analysis of bovine leukemia virus tax-responsive genes in ovine B cells

artículo científico publicado en 2006

Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells.

artículo científico publicado en 2015

Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.

artículo científico publicado en 2016

Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders

scientific article published on 01 August 2009

[Pimaricin therapy in mycotic complications of hemoblastosis]

scientific article published on 01 March 1972

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda